Diomed Developments Limited

Tatmore Place, Gosmore, Hitchin, Herts, SG4 7QR
Telephone: +44 (0)1462 458 866
Fax: +44 (0)1462 420 565
WWW: http://www.dermal.co.uk

Summary of Product Characteristics last updated on the eMC: 18/08/2009
SPC 4head Cutaneous Stick


Go to top of the page
1. NAME OF THE MEDICINAL PRODUCT

4HEAD™ CUTANEOUS STICK


Go to top of the page
2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Levomenthol 100% w/w.


Go to top of the page
3. PHARMACEUTICAL FORM

Cutaneous Stick.


Go to top of the page
4. CLINICAL PARTICULARS

Go to top of the page
4.1 Therapeutic indications

For the relief of headaches.


Go to top of the page
4.2 Posology and method of administration

4head is to be applied gently to the forehead. To be used as required, but excessive use avoided. If symptoms persist or worsen seek medical advice. For external topical application only.


Go to top of the page
4.3 Contraindications

Not recommended in patients where there is a known hypersensitivity to menthol.


Go to top of the page
4.4 Special warnings and precautions for use

Keep away from the eyes, levomenthol is irritant if allowed to come into contact with the eyes.

For single patient use only. For topical use - not to be taken.


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

None known.


Go to top of the page
4.6 Pregnancy and lactation

There is no information on safety when used during pregnancies and breast feeding, but there should be no hazard when applied as advised.


Go to top of the page
4.7 Effects on ability to drive and use machines

None known.


Go to top of the page
4.8 Undesirable effects

Menthol may give rise to hypersensitivity reactions including contact dermatitis. Because levomenthol is volatile, in rare cases it may cause temporary, mild watering of the eyes.


Go to top of the page
4.9 Overdose

If accidentally ingested menthol is reported to cause severe abdominal pain, nausea, vomiting, vertigo, ataxia, drowsiness and coma. Treatment for accidental ingestion is by emptying the stomach by gastric lavage. A saline laxative and activated charcoal should be administered. Convulsions may be controlled by the slow intravenous administration of diazepam. Haemodialysis with a lipid dialysate has been employed.


Go to top of the page
5. PHARMACOLOGICAL PROPERTIES

Go to top of the page
5.1 Pharmacodynamic properties

Applied to the skin, menthol dilates local blood vessels, causing a sensation of coldness, followed by an analgesic effect.


Go to top of the page
5.2 Pharmacokinetic properties

After absorption, menthol is excreted in the urine and bile as the glucuronide.


Go to top of the page
5.3 Preclinical safety data

No special information.


Go to top of the page
6. PHARMACEUTICAL PARTICULARS

Go to top of the page
6.1 List of excipients

None.


Go to top of the page
6.2 Incompatibilities

None known.


Go to top of the page
6.3 Shelf life

60 months.


Go to top of the page
6.4 Special precautions for storage

Do not store above 25˚C.

To be kept away from heat. (Melts at about 43˚C).


Go to top of the page
6.5 Nature and contents of container

Plastic twist-up dispenser containing 3.6 g menthol, with plastic cover.


Go to top of the page
6.6 Special precautions for disposal and other handling

To be applied as directed. For single patient use only.


Go to top of the page
7. MARKETING AUTHORISATION HOLDER

Diomed Developments Limited

Tatmore Place, Gosmore

Hitchin, Herts SG4 7QR, UK


Go to top of the page
8. MARKETING AUTHORISATION NUMBER(S)

00173/0193.


Go to top of the page
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

12 January 2009.


Go to top of the page
10. DATE OF REVISION OF THE TEXT

January 2009.



More information about this product

Link to this document from your website: http://emc.medicines.org.uk/medicine/19377/SPC/4head Cutaneous Stick/


Active Ingredients/Generics

 
   levomenthol


© 2010 Datapharm Communications Ltd

Go to www.medicines.org.uk